Literature DB >> 12094374

Expression of SSX genes in the neoplastic cells of Hodgkin's lymphoma.

Gisele W B Colleoni1, Paola Capodieci, Satish Tickoo, Jeffrey Cossman, Daniel A Filippa, Marc Ladanyi.   

Abstract

The cancer/testis antigen (CTA) group of tumor-associated proteins have been reported to be expressed in various cancers and in adult testis but they are essentially not found in any other normal adult nonneoplastic tissues. Prompted by the frequent detection of SSX1 in a previous comprehensive expression profile of the Hodgkin's lymphoma (HL) cell line L428, we analyzed SSX expression by nonnested reverse-transcription polymerase chain reaction (RT-PCR) in 4 HL cell lines (L428, L540, HD-MY-Z, and KM-H2) and 32 tumor samples of HL. The cellular localization of SSX expression in the tumor samples was further analyzed by in situ hybridization (ISH). All 4 HL cell lines were positive by RT-PCR using SSX consensus primers. Using primers specific to individual SSX genes, all 4 cell lines expressed multiple SSX family members. Five tumor samples (15.6%) were positive by RT-PCR using SSX consensus primers and direct sequencing of the RT-PCR products showed that 4 of 5 expressed more than 1 SSX family member. ISH confirmed that SSX expression originated in HL cells in all 5 RT-PCR-positive tumor samples. Furthermore, ISH demonstrated SSX-positive HL cells in 6 of 11 cases (55%) that were negative by RT-PCR. Our results suggest that members of the SSX family of CTA are expressed in most HL. This subset of HL may be a candidate for immunotherapy approaches directed at SSX proteins. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12094374     DOI: 10.1053/hupa.2002.124909

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

1.  Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma.

Authors:  Jessica A Shafer; Conrad R Cruz; Ann M Leen; Stephanie Ku; An Lu; Alexandra Rousseau; Helen E Heslop; Cliona M Rooney; Catherine M Bollard; Aaron E Foster
Journal:  Leuk Lymphoma       Date:  2010-05

2.  An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes.

Authors:  S Abdul-Rasool; S H Kidson; E Panieri; D Dent; K Pillay; G S Hanekom
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

3.  Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma.

Authors:  Ulrike Gerdemann; Usha Katari; Anne S Christin; Conrad R Cruz; Tamara Tripic; Alexandra Rousseau; Stephen M Gottschalk; Barbara Savoldo; Juan F Vera; Helen E Heslop; Malcolm K Brenner; Catherine M Bollard; Cliona M Rooney; Ann M Leen
Journal:  Mol Ther       Date:  2011-09-13       Impact factor: 11.454

4.  Expression of cancer testis antigen CT45 in classical Hodgkin lymphoma and other B-cell lymphomas.

Authors:  Yao-Tseng Chen; Amy Chadburn; Peishan Lee; Melinda Hsu; Erika Ritter; April Chiu; Sacha Gnjatic; Michael Pfreundschuh; Daniel M Knowles; Lloyd J Old
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

Review 5.  The SSX family of cancer-testis antigens as target proteins for tumor therapy.

Authors:  Heath A Smith; Douglas G McNeel
Journal:  Clin Dev Immunol       Date:  2010-10-11

6.  T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects.

Authors:  Spyridoula Vasileiou; Premal D Lulla; Ifigeneia Tzannou; Ayumi Watanabe; Manik Kuvalekar; Wendy L Callejas; Mrinalini Bilgi; Tao Wang; Mengfen J Wu; Rammurti Kamble; Carlos A Ramos; Rayne H Rouce; Zihua Zeng; Adrian P Gee; Bambi J Grilley; Juan F Vera; Catherine M Bollard; Malcolm K Brenner; Helen E Heslop; Cliona M Rooney; Ann M Leen; George Carrum
Journal:  J Clin Oncol       Date:  2021-01-28       Impact factor: 44.544

7.  An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients.

Authors:  Riguel J Inaoka; Achim A Jungbluth; Otávio Cg Baiocchi; Mariane Cg Assis; Nicole C Hanson; Denise Frosina; Jodie Tassello; Adriana B Bortoluzzo; Antonio C Alves; Gisele Wb Colleoni
Journal:  BMC Cancer       Date:  2011-09-28       Impact factor: 4.430

Review 8.  Histone deacetylase inhibitors in Hodgkin lymphoma.

Authors:  Daniela Buglio; Anas Younes
Journal:  Invest New Drugs       Date:  2010-12-03       Impact factor: 3.850

9.  SSX2 regulates focal adhesion but does not drive the epithelial to mesenchymal transition in prostate cancer.

Authors:  Jordan E Bloom; Douglas G McNeel
Journal:  Oncotarget       Date:  2016-08-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.